IntelGenx Technologies (QB) Stock Price

0.0196 (4.45%)


52 Week Range


Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Canna Trader Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
IntelGenx Technologies Corporation (QB) IGXT OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0196 4.45% 0.46 16:49:42
Open Price Low Price High Price Close Price Prev Close
0.44575 0.431 0.50 0.46 0.4404
Bid Price Ask Price Spread News
0.4278 0.516 0.0883 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
214 378,286 $ 0.471728 $ 178,448 - 0.1234 - 0.54
Last Trade Time Type Quantity Stock Price Currency
15:50:17 5,000 $ 0.46 USD

IntelGenx Technologies (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 51.51M 111.98M 100.91M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
118.25k $ - 0.00% - -

more financials information »

IntelGenx Technologies (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical IGXT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.501470.540.40370.4397666224,363-0.04147-8.27%
1 Month0.392730.540.365840.4663051398,1120.0672717.13%
3 Months0.234350.540.22190.3834583369,8680.2256596.29%
6 Months0.1527520.540.12340.3187312315,2290.30725201.14%
1 Year0.230.540.12340.2658763289,1700.23100.0%
3 Years0.661.830.1150.555494313,627-0.20-30.3%
5 Years0.561.830.1150.59871236,865-0.10-17.86%

IntelGenx Technologies (QB) Description

IntelGenx Corp. is a drug delivery company established in 2003 and headquartered in Montreal, Quebec, Canada. The Company's focus is on developing and manufacturing of novel oral thin film products for the pharmaceutical market. More recently, IntelGenx made the strategic decision to enter the Canadian cannabis market with a non-prescription cannabis infused oral film. IntelGenx's superior film technologies, including VersaFilm, VetaFilm and transdermal, allow for next generation pharmaceutical products that address unmet medical needs. The Company's innovative product pipeline offer significant benefits to patients and physicians for many therapeutic conditions. IntelGenx's highly skilled team provides comprehensive pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. IntelGenx's state-of-the-art manufacturing facility offers full service by providing lab-scale to pilot- and commercial-scale production. IntelGenx Corp. is the directly and indirectly fully owned Canadian operating company of IntelGenx Technologies Corp. The US parent IntelGenx Technologies Corp. is listed on the TSX-V Exchange and OTC-QB. For more information, visit www.intelgenx.com

Your Recent History
IntelGenx ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.